Order Benicar (olmesartan) online in the USA — prescription information, dosing, and savings

Product Name	Benicar (Benicar)
Dosage	5 mg, 20 mg, 40 mg
Active Ingredient	Olmesartan medoxomil
Form	Film‑coated oral tablets
Description	Benicar is an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension in adults and pediatric patients 6–16 years of age. Not for emergency treatment of hypertensive crisis. Boxed Warning: Do not use during pregnancy.
How to Get It in the U.S.	Prescription required. Many online pharmacies offer telehealth evaluations by licensed U.S. clinicians before dispensing.

Benicar (olmesartan medoxomil) is a long‑acting prescription medicine from the angiotensin II receptor blocker (ARB) class used across the United States to help lower high blood pressure. By blocking the effects of angiotensin II at the AT1 receptor, Benicar relaxes blood vessels, reduces vascular resistance, and can help protect the heart, brain, and kidneys from high blood pressure–related damage when used as part of a comprehensive treatment plan.

Benicar is dispensed only by prescription in the U.S. The tablets are available in three strengths — 5 mg, 20 mg, and 40 mg — and may be taken with or without food. Many patients begin therapy at 20 mg once daily and may be titrated to 40 mg once daily based on blood pressure response and tolerability. Generic olmesartan medoxomil is widely available nationwide and typically costs substantially less than the brand‑name product, while offering the same active ingredient, dosage strengths, and overall clinical effect.

Lowering blood pressure reduces the risk of major cardiovascular events, including stroke and myocardial infarction, when combined with lifestyle changes and, if needed, additional medications. Benicar can be used as monotherapy or together with other antihypertensives, such as thiazide diuretics (for example, olmesartan/hydrochlorothiazide combinations), calcium channel blockers, or other agents according to your clinician’s guidance.

Benicar price and ways to save in the USA

Pricing for antihypertensives varies widely by pharmacy, region, insurance coverage, and whether you choose a brand or generic product. In the United States, most patients pay significantly less when they select generic olmesartan medoxomil. Typical retail cash prices for generic olmesartan can range from approximately $7–$25 for a 30‑day supply at common dose strengths using widely available pharmacy discount programs, while brand‑name Benicar often costs more without insurance.

Estimated examples for generic olmesartan (consumer cash pay, using common in‑pharmacy coupons or discount cards):

- 30 tablets of 5 mg: often under $15 at many retail chains
- 30 tablets of 20 mg: frequently between $10 and $20
- 30 tablets of 40 mg: often between $12 and $25

Insurance copays for generics may be as low as a few dollars per month on many commercial plans and Medicare Part D formularies. Mail‑order pharmacies and 90‑day supplies can further reduce per‑tablet costs. Because prices change routinely, compare local pharmacies, check your insurer’s preferred options, and consider reputable mail‑order services.

Note: Prices are illustrative and can vary substantially by location and plan. Always confirm your final cost at checkout.

Where can I buy Benicar in the USA?

In the United States, Benicar and its generic, olmesartan medoxomil, are available by prescription at most community and hospital pharmacies, including national chains (such as CVS, Walgreens, Walmart, and Kroger) and independent pharmacies. You can also use legitimate U.S. online pharmacies and mail‑order services that dispense prescription medications following a valid clinician assessment.

If you don’t already have a prescription, many online platforms provide a telehealth consultation with a licensed U.S. provider. After your medical evaluation and if appropriate, a prescription can be issued and sent to the pharmacy of your choice for home delivery or pickup. Always verify that the online pharmacy is properly licensed in the state where you live, uses U.S.‑licensed clinicians and pharmacists, and requires a valid prescription. Helpful markers of legitimacy include participation in state boards of pharmacy programs and transparency around company address, licensure, and pharmacist contact.

Choosing a pharmacy that offers clear pricing, timely shipping, and accessible pharmacist support can make medication management easier and help you stay on track with your blood pressure goals.

Benicar in the United States

Getting Benicar in the U.S. is straightforward: you need a prescription from a licensed clinician. Many patients obtain it through a primary care provider, cardiologist, or an accredited telehealth service. Once prescribed, you may fill it at your local pharmacy or use a U.S. mail‑order pharmacy for convenient home delivery, often with cost savings for 90‑day supplies.

What is Benicar (olmesartan)?

Benicar contains olmesartan medoxomil, a prodrug that is rapidly converted in the body to olmesartan, an angiotensin II receptor antagonist. By selectively blocking the AT1 receptor, it blunts the vasoconstrictor and aldosterone‑secreting effects of angiotensin II. The result is vasodilation, reduced afterload, and decreased blood pressure. ARBs like olmesartan do not inhibit ACE or bradykinin breakdown and are therefore less likely to cause cough compared with ACE inhibitors.

Indication in the U.S.: Treatment of hypertension in adults and in pediatric patients 6–16 years of age to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

Limitations of use: Benicar is not indicated for the initial treatment of severe hypertension, hypertensive emergencies, or heart failure; and should not be used in pregnancy. Combination therapy may be needed to achieve blood pressure targets depending on the patient’s baseline and comorbidities.

How Benicar works to lower blood pressure

Olmesartan specifically targets the angiotensin II type 1 (AT1) receptor on vascular smooth muscle and adrenal gland tissue. Blocking AT1 receptors prevents angiotensin II from causing vasoconstriction and aldosterone release. Reduced aldosterone leads to decreased sodium and water retention, while vasodilation lowers systemic vascular resistance. Together, these effects reduce blood pressure. The onset of antihypertensive action is typically within 1–2 weeks, with maximal effect observed by about 4 weeks of continued daily dosing.

As with all antihypertensives, clinical benefits are greatest when Benicar is part of a comprehensive plan that includes lifestyle modification: a healthy diet (e.g., DASH), sodium reduction, regular physical activity, moderation of alcohol intake, smoking cessation, weight management, and stress reduction.

Dosing and administration

Adults: The usual starting dose is 20 mg once daily. If additional blood pressure reduction is needed after 2 weeks, the dose may be increased to 40 mg once daily. Doses above 40 mg have not shown added benefit. For patients who require further reduction in blood pressure, a thiazide diuretic (e.g., hydrochlorothiazide) may be added. Benicar may be taken with or without food, preferably at the same time each day.

Pediatric patients (6–16 years): Dosing is weight‑based. A typical regimen may start at 10–20 mg once daily, with adjustments based on weight and response. Children under 1 year should not receive olmesartan due to the risk of kidney development issues; safety and efficacy are not established for those under 6 years for tablets. Pediatric dosing should be individualized and supervised by a pediatric clinician experienced in hypertension management.

Renal or hepatic impairment: No specific initial dose adjustment is typically required for mild to moderate renal impairment; however, careful monitoring of renal function and serum potassium is recommended. Use with caution in patients with severe renal impairment or in those with hepatic impairment. In patients with possible volume depletion (e.g., on high‑dose diuretics), consider a lower starting dose and correct volume status prior to initiation to reduce the risk of symptomatic hypotension.

Important safety warnings (including pregnancy)

Boxed Warning — Fetal toxicity: Drugs that act directly on the renin–angiotensin system can cause injury and death to the developing fetus. Discontinue Benicar as soon as pregnancy is detected. Patients of childbearing potential should be counseled on effective contraception while taking olmesartan. If a patient becomes pregnant, the prescriber should switch to an alternative antihypertensive agent with a better‑established safety profile in pregnancy.

Sprue‑like enteropathy: Severe, chronic diarrhea with substantial weight loss has been reported with olmesartan, sometimes occurring months to years after starting treatment. If a patient develops such symptoms without another identified cause, discontinue olmesartan. Most patients improve after stopping the drug.

Hypotension and renal function changes: Symptomatic hypotension can occur, particularly in patients who are volume‑ or salt‑depleted (for example, due to diuretic use, vomiting, or diarrhea). Transient increases in BUN/serum creatinine may occur, especially in those with renal artery stenosis or severe congestive heart failure. Monitor renal function periodically and consider dosage adjustments or alternative therapy if clinically significant changes occur.

Hyperkalemia: Increases in serum potassium can occur, especially with concomitant use of potassium supplements, potassium‑sparing diuretics, or other agents that raise potassium (such as ACE inhibitors or aliskiren). Monitor electrolytes as clinically indicated.

Common and serious side effects

Most people tolerate olmesartan well. The following information summarizes potential adverse effects; it is not exhaustive. Always review the Medication Guide and consult your healthcare professional.

Common side effects may include:

• Dizziness or lightheadedness, particularly when standing up quickly
• Headache or fatigue
• Upper respiratory symptoms such as nasopharyngitis
• Diarrhea (mild)

Less common but important adverse effects:

• Sprue‑like enteropathy (severe, chronic diarrhea and weight loss)
• Hypotension (especially in volume‑depleted patients)
• Renal impairment or changes in kidney function tests
• Hyperkalemia (high potassium)
• Angioedema (rare; swelling of the face, lips, tongue, or throat — seek emergency care)

Seek medical attention promptly for symptoms of an allergic reaction (e.g., difficulty breathing, severe rash, swelling) or signs of dangerously low blood pressure (fainting, confusion, severe weakness) or severe abdominal symptoms suggestive of enteropathy.

Drug interactions

Tell your doctor and pharmacist about all prescription and over‑the‑counter medicines, vitamins, and herbal supplements you take. Important interactions may include:

• Potassium‑sparing diuretics (e.g., spironolactone, eplerenone) and potassium supplements — increased risk of hyperkalemia
• ACE inhibitors, aliskiren — dual blockade of the renin–angiotensin system increases risk of hypotension, hyperkalemia, and renal dysfunction; avoid in most patients (especially avoid aliskiren in diabetes)
• NSAIDs (e.g., ibuprofen, naproxen) — may reduce antihypertensive effect and increase risk of renal impairment, especially in older adults or those volume‑depleted
• Lithium — possible increase in lithium toxicity; monitor lithium levels closely or consider alternatives
• Other agents that lower blood pressure (e.g., diuretics, calcium channel blockers, alpha‑blockers) — additive hypotensive effects; monitor clinically

This list is not complete. Always share an updated medication list with your healthcare providers. Your clinician may adjust doses or monitor specific labs to reduce the risk of adverse interactions.

Monitoring and follow‑up

To ensure safety and effectiveness, routine monitoring is recommended:

• Blood pressure: Check at home between visits using a validated cuff; bring readings to appointments
• Renal function: Baseline and periodic serum creatinine/BUN, especially after dose changes or when adding interacting drugs
• Electrolytes: Check serum potassium at baseline and periodically, more often if on potassium‑raising agents
• Symptoms: Report persistent diarrhea, unexplained weight loss, severe fatigue, lightheadedness, or swelling

Your clinician may adjust the dose or recommend adding another antihypertensive when further blood pressure reduction is needed.

Benicar vs. other ARBs and combination options

ARBs commonly used in the U.S. include losartan, valsartan, irbesartan, candesartan, telmisartan, and olmesartan. While all are effective at lowering blood pressure, differences exist in dosing frequency, available strengths, pharmacokinetics, and cost. Some clinicians prefer ARBs for patients who developed cough with ACE inhibitors. Choice among ARBs often reflects patient‑specific factors, tolerability, and insurance coverage.

Combination therapy: Many patients need two or more agents to reach targets. Benicar can be paired with a thiazide diuretic (e.g., olmesartan/hydrochlorothiazide) or a calcium channel blocker. Fixed‑dose combination tablets may improve adherence by simplifying regimens, but they may not offer the flexibility of adjusting individual components separately.

How to take Benicar correctly

- Take once daily at the same time each day, with or without food.
- Swallow tablets whole with water; do not crush unless instructed by your clinician and pharmacist.
- If you miss a dose, take it as soon as you remember the same day. If it’s almost time for your next dose, skip the missed dose — do not double up.
- Continue taking Benicar even if you feel well. High blood pressure often has no symptoms, and stopping suddenly can raise your risk for complications.
- Do not use during pregnancy. If you plan to become pregnant or think you may be pregnant, contact your clinician immediately to switch to a safer alternative.

Lifestyle changes that complement Benicar

Medication works best alongside evidence‑based lifestyle strategies. The American College of Cardiology/American Heart Association (ACC/AHA) recommends:

• DASH‑style eating pattern rich in fruits, vegetables, whole grains, and lean proteins
• Sodium reduction to ideally under 1,500–2,300 mg per day, as advised by your clinician
• Regular physical activity (e.g., 150 minutes/week of moderate‑intensity aerobic exercise, plus strength training)
• Weight management to achieve or move toward a healthy BMI
• Limiting alcohol (no more than 2 drinks/day for men, 1 drink/day for women)
• Smoking cessation and avoidance of nicotine products

These approaches can improve blood pressure control, reduce cardiovascular risk, and sometimes allow for lower medication doses.

Special populations and clinical considerations

Elderly: Start at the lower end of the dosing range and monitor for hypotension and renal function changes.

Black patients: Monotherapy with an ARB may be less effective than in non‑Black patients; a thiazide diuretic or calcium channel blocker is often added. Therapy should be individualized to meet targets and comorbidity needs.

Diabetes and kidney disease: ARBs are often preferred when albuminuria is present; monitor serum creatinine and potassium closely, especially with other renin–angiotensin system agents or NSAIDs.

Hepatic impairment: Use with caution; monitor clinically.

Breastfeeding: Data on olmesartan excretion into human milk are limited. Discuss risks and alternatives with your clinician before use while nursing.

Insurance coverage and affordability

Generic olmesartan is included on many U.S. insurance formularies and is generally affordable. To optimize costs:

• Ask your clinician to prescribe generic olmesartan medoxomil unless brand is specifically needed
• Use a 90‑day supply via mail order when possible
• Compare pharmacies and use reputable discount programs
• Review your plan’s preferred pharmacies and tiered copays

Medicare Part D beneficiaries and those with commercial insurance should review plan details during the enrollment period to ensure their preferred medications remain covered at reasonable copays.

Frequently asked questions (FAQ)

How long until Benicar starts working? Many people notice improvements within 1–2 weeks, with full effect by about 4 weeks.

Can I drink alcohol? Alcohol can further lower blood pressure and increase dizziness. If you drink, do so in moderation and discuss with your clinician.

What if my blood pressure is still high on Benicar alone? Your clinician may increase the dose to 40 mg or add a second medication (e.g., a thiazide diuretic). Home BP monitoring helps guide adjustments.

Is Benicar safe long term? ARBs are widely used for chronic management of hypertension. Ongoing monitoring of blood pressure, renal function, and electrolytes supports safe long‑term use.

Is Benicar the same as Benicar HCT? No. Benicar HCT combines olmesartan with hydrochlorothiazide (a diuretic). Your clinician will determine which option fits your clinical profile.

Mechanism of action (clinical overview)

Benicar acts by antagonizing AT1 receptors to prevent angiotensin II from exerting vasoconstrictor and aldosterone‑mediated effects. This reduces peripheral resistance and modestly promotes natriuresis through decreased aldosterone activity. Unlike ACE inhibitors, ARBs typically do not cause bradykinin‑mediated cough. Pharmacokinetics: After oral administration, olmesartan medoxomil is converted to olmesartan; peak plasma concentrations occur within 1–3 hours, and the terminal elimination half‑life is approximately 13 hours, allowing for once‑daily dosing.

Safety profile and tolerability

Across clinical trials, discontinuation due to adverse effects has been uncommon and similar to placebo. Dizziness and fatigue are among the most frequently reported effects. Serious but rare events include angioedema and sprue‑like enteropathy. Risk of hyperkalemia increases when combined with potassium‑sparing diuretics or supplements. Appropriate patient selection, counseling, and monitoring minimize risk.

Adult dosing guidance

Most adults start at 20 mg once daily. Reassess blood pressure after 2–4 weeks and titrate as needed. If home readings remain above target, discuss adherence, lifestyle factors, other medications (including NSAIDs and decongestants), and consider combination therapy. Do not exceed 40 mg daily of olmesartan.

Titration and treatment goals

Current U.S. guidelines often recommend a target of under 130/80 mmHg for many adults, especially those at elevated cardiovascular risk, when treatment is well tolerated. Individualize goals based on age, comorbidities, frailty, and clinician guidance.

Renal considerations

In patients with bilateral renal artery stenosis or stenosis of the artery to a solitary kidney, olmesartan and other drugs affecting the renin–angiotensin system can cause increases in serum creatinine or acute renal failure. Monitor kidney function carefully and discontinue if a clinically significant decline occurs. In patients with chronic kidney disease, ARBs may be beneficial, particularly when albuminuria is present, but require routine monitoring of potassium and creatinine.

Switching from other antihypertensives

When transitioning from another ARB, ACE inhibitor, or different antihypertensive class, your clinician will recommend an appropriate washout and starting regimen based on your prior drug’s half‑life, blood pressure readings, and clinical status. Avoid dual renin–angiotensin system blockade (e.g., combining an ACE inhibitor and an ARB) except in rare, specialist‑directed scenarios due to increased risk of adverse events.

Who should not take Benicar

Do not take Benicar if you are pregnant or plan to become pregnant. Do not use it together with aliskiren if you have diabetes. Use with caution (or avoid) in patients with a history of angioedema on ARBs/ACE inhibitors, those with severe renal impairment without close monitoring, or in conditions where hypotension could be dangerous.

Benicar side effects — what to watch for

While many effects are mild and transient, contact your clinician if symptoms persist or worsen:

• Dizziness, lightheadedness, or fainting
• Persistent diarrhea or unexplained weight loss
• Signs of high potassium (muscle weakness, irregular heartbeat)
• Swelling of the face, lips, tongue, or throat (angioedema)
• Decreased urine output or swelling suggesting kidney issues

This is not a complete list. Review the full Medication Guide and ask your pharmacist for details regarding your specific situation.

Reporting side effects

If you experience side effects, speak with your healthcare provider or pharmacist. In the U.S., you can report adverse events to FDA MedWatch at 1‑800‑FDA‑1088 or online at www.fda.gov/medwatch.

Interaction details for Benicar

Some interactions may increase the risk of hypotension, kidney problems, or hyperkalemia. Examples include:

• Potassium‑sparing diuretics (spironolactone, eplerenone), potassium supplements, or salt substitutes containing potassium
• ACE inhibitors or aliskiren (especially in patients with diabetes)
• NSAIDs, particularly with dehydration or existing kidney disease
• Lithium — risk of toxicity; monitor levels

Provide your clinicians with a complete list of your medications to help prevent or manage potential interactions.

Recommendations from our clinical team

Achieving and maintaining your target blood pressure substantially reduces cardiovascular risk. Our team recommends pairing Benicar with consistent home blood pressure monitoring, lifestyle modifications, and regular follow‑up to assess response and tolerability. If you’re starting therapy via an online platform, ensure it provides care from U.S.‑licensed clinicians, clear instructions, and access to pharmacists who can answer your questions.

Ready to take control of your blood pressure? Order Benicar responsibly

Request a prescription evaluation online and have Benicar delivered to your door from a trusted U.S. pharmacy partner.

• Prescription required in the U.S. — quick, secure telehealth evaluation available
• Fast home delivery from licensed pharmacies across the United States
• Authentic medication supplied by regulated U.S. distributors
• Flexible quantities and strengths (5 mg, 20 mg, 40 mg)
• Helpful support from experienced pharmacists and customer care

Join millions of Americans who safely manage blood pressure with proven therapies. Begin your Benicar journey today with clinician‑guided care and reliable pharmacy service.

Buy Benicar Now